New asthma drug TR4 shows promise in early safety trial
NCT ID NCT07272135
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This early-stage study tested a new drug, TR4, in 12 adults with mild-to-moderate asthma. The goal was to check if the drug is safe and how it affects the airways. Participants received either TR4 or a placebo, and researchers measured lung function and other health markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hammersmith Medicines Research
London, London, NW10 7EW, United Kingdom
Conditions
Explore the condition pages connected to this study.